HomeALTME • EPA
add
TME Pharma NV
Nakaraang pagsara
0.074
Sakop ng araw
0.072 - 0.076
Sakop ng taon
0.049 - 0.15
Market cap
7.55M
Average na Volume
434.01K
P/E ratio
-
Dividend yield
-
Primary exchange
EPA
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (EUR) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 13.50K | — |
Gastos sa pagpapatakbo | 982.00K | -28.24% |
Net na kita | -1.05M | 35.28% |
Net profit margin | -7.79K | — |
Kita sa bawat share | — | — |
EBITDA | -965.00K | 27.74% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (EUR) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 2.06M | -23.79% |
Kabuuang asset | 2.29M | -22.06% |
Kabuuang sagutin | 2.86M | 108.22% |
Kabuuang equity | -570.00K | — |
Natitirang share | 94.09M | — |
Presyo para makapag-book | -7.38 | — |
Return on assets | -105.59% | — |
Return on capital | -210.54% | — |
Cash Flow
Net change in cash
| (EUR) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -1.05M | 35.28% |
Cash mula sa mga operasyon | -1.43M | -4.57% |
Cash mula sa pag-invest | 4.00K | 200.00% |
Cash mula sa financing | 836.00K | -47.78% |
Net change in cash | -590.00K | -357.64% |
Malayang cash flow | -656.00K | 9.28% |
Tungkol
TME Pharma, formerly NOXXON Pharma, is a biotechnology company founded in 1997 in Berlin, Germany which specialises on cancer treatment by targeting the tumor microenvironment. TME Pharma N.V. is listed on Euronext Growth, Paris and is a member of the German Association of Research-Based Pharmaceutical Companies, Verband forschender Arzneimittelhersteller.
TME Pharma develops drugs using technology yielding L-RNA molecules, which are of mirror-image configuration compared to naturally occurring D-RNA molecules. The company calls these agents Spiegelmers, from Spiegel, the German word for "mirror."
The L-RNA are resistant to the natural RNA nuclease enzymes. Wikipedia
Itinatag
1997
Website
Mga Empleyado
12
